Hydroxyzine and Cymbalta (Duloxetine) Combination
Hydroxyzine can be safely combined with duloxetine (Cymbalta) with appropriate monitoring for CNS depression and sedation, though this combination offers no therapeutic advantage over monotherapy for anxiety or depression.
Key Safety Considerations
CNS Depression Risk
The FDA label for hydroxyzine explicitly warns that "THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS" 1. When combining these medications:
- Start with reduced doses of both agents if initiating simultaneously
- Monitor closely for excessive sedation, particularly in the first 1-2 weeks
- Counsel patients to avoid alcohol and other CNS depressants
- Use particular caution in elderly patients, who are more susceptible to confusion and over-sedation 1
Cardiovascular Monitoring
Both medications carry cardiac considerations:
Hydroxyzine:
- Can cause QT prolongation and Torsade de Pointes 1
- Risk increases with concomitant use of other QT-prolonging drugs
- Certain antidepressants including citalopram and fluoxetine are specifically listed as QT-prolonging agents to use cautiously with hydroxyzine 1
- While duloxetine is not explicitly listed, obtain baseline ECG in high-risk patients
Duloxetine:
- Monitor blood pressure before and during treatment 2
- Can increase systolic BP by 4.7-6.8 mmHg and diastolic by 4.5-7 mmHg at higher doses 2
Clinical Efficacy Evidence
The combination provides no added benefit. Research directly examining hydroxyzine plus duloxetine for anxiety found that "combination of duloxetine with hydroxyzine is not beneficial in anxiolytic treatment than the respective monotherapies" 3. The combination showed similar results to either drug alone in anxiety models.
Older research on SSRIs suggests hydroxyzine may be preferable to benzodiazepines when combining with serotonergic antidepressants, as benzodiazepines can antagonize the therapeutic effects of SSRIs 4. However, this does not translate to enhanced efficacy with combination therapy.
Practical Management Algorithm
If prescribing both medications:
Assess baseline risk factors:
- Cardiac history (obtain ECG if age >40, cardiac disease, or other QT risk factors)
- Baseline blood pressure
- Renal function (both drugs require adjustment in severe renal impairment)
- Hepatic function (duloxetine contraindicated in hepatic insufficiency) 2
Dosing approach:
- Start duloxetine at 30 mg daily for 1 week, then increase to 60 mg [@2,3,4@]
- Use hydroxyzine 25-50 mg at bedtime if needed for sleep or anxiety 5
- Avoid hydroxyzine doses >100 mg daily
Monitoring schedule:
Patient counseling:
- Warn about additive drowsiness - no driving until effects known
- Avoid alcohol completely (duloxetine + alcohol = severe liver injury risk) 2
- Report dizziness, palpitations, or syncope immediately (QT concerns)
Common Pitfalls to Avoid
- Don't assume synergistic benefit - evidence shows no advantage to combination 3
- Don't overlook fall risk in elderly - both cause sedation and hydroxyzine specifically warns about elderly sensitivity 1
- Don't forget renal dosing - hydroxyzine is renally excreted; duloxetine contraindicated in severe renal impairment (CrCl <30) 2
- Don't combine with heavy alcohol use - duloxetine is contraindicated 2
When This Combination Makes Sense
The combination is reasonable when:
- Duloxetine prescribed for depression/neuropathic pain [@2,3,4@] AND
- Short-term hydroxyzine needed for acute anxiety or insomnia 5 AND
- Patient has failed or cannot tolerate benzodiazepines
However, consider alternative strategies first: optimize duloxetine dosing (up to 120 mg/day for depression per guidelines 6), add psychotherapy, or use non-pharmacologic sleep interventions before adding hydroxyzine.